Fact check
“ProPublica used the DUNS number to collect data for Rx Inspector.”
Reasoning
The provided evidence directly quotes ProPublica describing the use of the DUNS (unique facility identification) number to gather data for the Rx Inspector tool, confirming the claim.
On confidence: Multiple excerpts from the same ProPublica article explicitly state that ProPublica used the DUNS number to collect data for Rx Inspector.
Important context
The DUNS number is a unique facility identifier that can link generic drugs to specific manufacturing sites, and ProPublica leveraged this identifier in building Rx Inspector.
Evidence
Supporting (4)
- Tier 1 — Primary sourceClear Labels Act Stripped of Critical Drug Safety Provisions — ProPublica
requirement to include a unique facility identification number on labels, called a DUNS number, which would have allowed the public to more easily trace a generic drug and its active ingredients to the factories where they were made. In…
- Tier 1 — Primary sourceClear Labels Act Stripped of Critical Drug Safety Provisions — ProPublica
generic drug and its active ingredients to the factories where they were made. In some cases, that identifier could also be used to find FDA inspection reports that describe contamination and other safety breakdowns on factory floors. Read…
- Tier 1 — Primary sourceClear Labels Act Stripped of Critical Drug Safety Provisions — ProPublica
the bill’s updated language, drug labels will only be required to include factory addresses, which can be inconsistent and hard to trace to a manufacturing facility. A single address in India, for example, can house multiple factories,…
- Tier 1 — Primary sourceClear Labels Act Stripped of Critical Drug Safety Provisions — ProPublica
are already using the tool to learn more about the drugs they take and prescribe . Under the bill’s updated language, drug labels will only be required to include factory addresses, which can be inconsistent and hard to trace to a…
Limitations
All evidence comes from a single ProPublica article; no independent third‑party sources are provided to corroborate the statement.
- Last verified:
- Sep 27, 2026, 4:24 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
“A Clear Watering Down”: Drug Transparency Bill Stripped of Critical Provisions Ahead of Senate VoteProPublica · Naisha Roy